Nursing homes and residential care facilities are undergoing a sea change as the many benefits of aging in place are seen, and people are beginning to refuse to leave their homes.
After yielding promising results in a clinical trial, an LSD formulation aimed at treating generalized anxiety disorder has been awarded Breakthrough Therapy status by the U.S. Food and Drug Administration.